PEGylated polymeric delivery systems such as PEGylated liposomal doxorubicin is highly desirable in clinic cancer treatment, and approve so far minimize toxicity [6], [7], [8]. However, they fail to significantly improve the therapeutic efficacy because PEGylation also blocks tumoral cellular uptake...